why does nobody talk about thymosin
why does nobody talk about thymosin. I would rather ask a basic question now than get this wrong quietly for two months. Naming in this space is inconsistent. Several widely used names map to more than one molecule, so a catalogue number and a sequence beat a common name every time. Purity methods differ by compound…
Stocked lines and made-to-order lines have different lead times and different storage histories. Both are ordinary; the difference is worth confirming before you commit.
if nobody has tested it here, that is a fact about us, not the compound
Asked TFC which lines they keep in regional stock versus make to order and got a clear split. It changed what I ordered.
Right — Homopeptide answered a handling question with actual storage conditions rather than a generic line, which is the standard.
Right — Homopeptide answered a handling question with actual storage conditions rather than a generic line, which is the standard.
Disagreeing with this bit: handling for one compound does not transfer to another by default.
Right — Homopeptide answered a handling question with actual storage conditions rather than a generic line, which is the standard.
insulin_syringe_ian is right that a purity figure without a method is not comparable to one with a method.
Disagree — that name refers to at least two different molecules depending on who is selling it. The thread needs to be specific.
Stocked lines and made-to-order lines have different lead times and different storage histories.
Adding the practical question — stocked or made to order, and what is the lead time.
Careful — that is a claim about efficacy and there is essentially no human evidence behind it.
Agreed — identity first for anything off the well-travelled list. The purity number is meaningless until you know what it is pure of.
Agreed — identity first for anything off the well-travelled list.
Agreed — and the naming problem is worse than most people here realise.